Abbvie US LLC

North Chicago, IL

UEI
MAB9Y43Z1US6
CAGE
6XMS3
Primary NAICS
325414 Biological Product (except Diagnostic) Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
Corporate Entity (Not Tax Exempt)
Corporate family
SAM.gov registration date
Physical address
1 N Waukegan Rd, North Chicago, IL 60064, USA
Website
abbvie.com
Founded
2013
Employees
10K-50K
Estimated annual revenue
$10B+
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $131,655
FY2025 $302,385
FY2024 $49,402
FY2023 $57,991

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Veterans Affairs $81,560
2 Department of Health and Human Services $50,095

Contract vehicles

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Abbvie US LLC is a for-profit limited liability company subsidiary of the global biopharmaceutical company Abbvie Inc., headquartered in North Chicago, Illinois. The company specializes in providing pharmaceutical products, medical devices, and specialized medical implants to federal healthcare agencies, establishing itself as a significant federal contractor with a diverse portfolio of indefinite delivery/indefinite quantity contracts and direct delivery orders serving the Department of Veterans Affairs, Indian Health Service, and other federal healthcare providers.

Abbvie US LLC has delivered an extensive range of medical products and pharmaceutical supplies through federal contract awards since 2021, demonstrating specialized expertise in multiple product categories. The company has supplied prosthetics and implants, including breast implants, biological implants, and prosthesis posts, primarily through the Department of Veterans Affairs Veterans Integrated Service Networks 1, 2, 7, 9, 20, and 22, as well as through the Indian Health Service at the Phoenix Indian Medical Center. Pharmaceutical deliveries have focused on specialized Parkinson's disease treatments, including DUOPA (levodopa-carbidopa enteral suspension) and VYALEV (levodopa-carbidopa suspension), supplied to multiple VA networks and facilities across locations including Shawnee, Kansas. The company has also provided Allergan breast implant supplies through the Indian Health Service. All contract awards reviewed indicate non-competitive or competitive procurements without set-aside designations, reflecting Abbvie US LLC's standing as an open-market federal contractor. Contract vehicles have included firm fixed-price purchase orders, delivery orders, and blanket purchase agreement calls, with ceiling values ranging from approximately $1,350 to $164,749 for individual task orders. The company consistently performs work at its North Chicago, Illinois facility, though some deliveries have occurred at alternative performance locations such as Phoenix, Arizona and Shawnee, Kansas.

Abbvie US LLC currently maintains four significant indefinite delivery/indefinite quantity contracts serving federal healthcare agencies. The most substantial is a $12.1 billion Federal Supply Schedule contract (FSS-61-IB for Pharmaceuticals and Drugs) awarded by Veterans Integrated Service Network 12, effective through June 30, 2030, supporting the VA's procurement of drugs, pharmaceuticals, and hematology-related products across its medical center network. A complementary $15 million single-award Blanket Purchase Agreement with the VA National Acquisition Center, awarded August 1, 2025, specifically covers DUOPA and VYALEV medications through July 31, 2026 and incorporates 2026 Public Law pricing updates. Abbvie US LLC also holds a $13.2 million Federal Supply Schedule contract (FSS-65-II-A for Medical Equipment and Supplies) awarded by Veterans Integrated Service Network 12, valid through November 30, 2029, enabling procurement of medical equipment and supplies for both VA and Indian Health Service facilities. Additionally, the company maintains a $259,621 single-award Blanket Purchase Agreement with the Indian Health Service, established December 7, 2023 and running through December 12, 2028, for Allergan brand breast implant supplies at the Phoenix Indian Medical Center. These IDV vehicles facilitate streamlined task order issuance without requiring competitive re-solicitation, positioning Abbvie US LLC as a pre-positioned supplier for critical pharmaceutical and medical device needs across the federal healthcare system.

Quick answers

Is Abbvie US LLC registered in SAM.gov?

Yes. Abbvie US LLC's SAM.gov registration is active through August 18, 2027.

Which contract vehicles does Abbvie US LLC hold?

Abbvie US LLC holds a place on 2 federal contract vehicles, including FSS-65-II-A and FSS-61-IB.

How much has Abbvie US LLC received in federal contracts?

Federal contracts obligated $302,385 to Abbvie US LLC in fiscal year 2025 and $541,433 in fiscal years 2023 through 2027.

What is Abbvie US LLC's most recent federal award?

Abbvie US LLC's most recent federal contract award is Prosthetics:implant (36C26226P0366), from Veterans Integrated Service Network 22 (VHA), on January 7, 2026.

On GovTribe

See Abbvie US LLC's full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors